Literature DB >> 17458672

Molecular epidemiology of uropathogenic Escherichia coli.

Shingo Yamamoto1.   

Abstract

Escherichia coli is the most common cause of complicated as well as uncomplicated urinary tract infections (UTIs). Most of these uropathogenic E. coli (UPEC) strains exhibit certain virulence factors (VFs), including adhesins, iron uptake systems, synthesis of cytotoxins, and specific O:K:H serotypes. Molecular epidemiological studies of UPEC have contributed to the discovery of uropathogenic VFs, to an understanding of the pathogenesis of UTIs as ascending infections, and to the clarification of genetic linkages between different virulence genes such as pathogenicity islands (PAIs), which are one of the mechanisms for horizontal VF gene transfers between the same or related species. Uropathogenic VFs not only play an important role individually but also work cooperatively in a fine-tuned manner with coordinated regulation and expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458672     DOI: 10.1007/s10156-007-0506-y

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  29 in total

1.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.

Authors:  Jonas Marschall; Lixin Zhang; Betsy Foxman; David K Warren; Jeffrey P Henderson
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

3.  Genotypic Analysis of E. coli Strains Isolated from Patients with Cystitis and Pyelonephritis.

Authors:  M Anvarinejad; Sh Farshad; R Ranjbar; G M Giammanco; A Alborzi; A Japoni
Journal:  Iran Red Crescent Med J       Date:  2012-07-30       Impact factor: 0.611

4.  Genotypic Characterization of Virulence Factors in Escherichia coli Isolated from Patients with Acute Cystitis, Pyelonephritis and Asymptomatic Bacteriuria.

Authors:  Mohsen Tabasi; Mohammad Reza Asadi Karam; Mehri Habibi; Ehsan Mostafavi; Saeid Bouzari
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  Temperature control of fimbriation circuit switch in uropathogenic Escherichia coli: quantitative analysis via automated model abstraction.

Authors:  Hiroyuki Kuwahara; Chris J Myers; Michael S Samoilov
Journal:  PLoS Comput Biol       Date:  2010-03-26       Impact factor: 4.475

6.  Measurement of tactile allodynia in a murine model of bacterial prostatitis.

Authors:  Marsha L Quick; Joseph D Done; Praveen Thumbikat
Journal:  J Vis Exp       Date:  2013-01-16       Impact factor: 1.355

7.  (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR.

Authors:  Wioletta Adamus-Bialek; Arkadiusz Wojtasik; Marta Majchrzak; Marek Sosnowski; Pawel Parniewski
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 8.  Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Authors:  Amelia E Barber; J Paul Norton; Travis J Wiles; Matthew A Mulvey
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

9.  ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis.

Authors:  Van Phan; Robert Belas; Brendan F Gilmore; Howard Ceri
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

10.  Virulence properties of uropathogenic Escherichia coli isolated from children with urinary tract infection in Korea.

Authors:  Dong Ho Kim; Bindu Subhadra; Hee Young Kang; Kyungho Woo; Jaeseok Kim; Yeo-Jin Son; Kyung Mok Sohn; Hwa-Jung Kim; Kyudong Han; Man Hwan Oh; Chul Hee Choi
Journal:  Genes Genomics       Date:  2018-02-14       Impact factor: 1.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.